These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 25304421)
1. Effect of preventive and curative interventions on hepatitis C virus transmission in Egypt (ANRS 1211): a modelling study. Breban R; Arafa N; Leroy S; Mostafa A; Bakr I; Tondeur L; Abdel-Hamid M; Doss W; Esmat G; Mohamed MK; Fontanet A Lancet Glob Health; 2014 Sep; 2(9):e541-e549. PubMed ID: 25304421 [TBL] [Abstract][Full Text] [Related]
2. Progress toward prevention and control of hepatitis C virus infection--Egypt, 2001-2012. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2012 Jul; 61(29):545-9. PubMed ID: 22832935 [TBL] [Abstract][Full Text] [Related]
3. Incidence of hepatitis c virus seroconversion among hemodialysis patients in the Nile Delta of Egypt: A single-center study. Kamal AT; Farres MN; Eissa AM; Arafa NA; Abdel-Reheem RS Saudi J Kidney Dis Transpl; 2017; 28(1):107-114. PubMed ID: 28098111 [TBL] [Abstract][Full Text] [Related]
4. Reduced incidence of hepatitis C in 9 villages in rural Egypt: Progress towards national elimination goals. Shiha G; Soliman R; Mikhail NNH; Easterbrook P J Hepatol; 2021 Feb; 74(2):303-311. PubMed ID: 32931878 [TBL] [Abstract][Full Text] [Related]
5. Psychiatric and substance use disorders in HIV/hepatitis C virus (HCV)-coinfected patients: does HCV clearance matter? [Agence Nationale de Recherche sur le SIDA et les Hépatites Virales (ANRS) HEPAVIH CO13 cohort]. Michel L; Lions C; Winnock M; Lang JP; Loko MA; Rosenthal E; Marchou B; Valantin MA; Morlat P; Roux P; Sogni P; Spire B; Poizot-Martin I; Lacombe K; Lascoux-Combe C; Duvivier C; Neau D; Dabis F; Salmon-Ceron D; Carrieri MP; HIV Med; 2016 Nov; 17(10):758-765. PubMed ID: 27187027 [TBL] [Abstract][Full Text] [Related]
6. The epidemiology and iatrogenic transmission of hepatitis C virus in Egypt: a Bayesian coalescent approach. Pybus OG; Drummond AJ; Nakano T; Robertson BH; Rambaut A Mol Biol Evol; 2003 Mar; 20(3):381-7. PubMed ID: 12644558 [TBL] [Abstract][Full Text] [Related]
7. HCV iatrogenic and intrafamilial transmission in Greater Cairo, Egypt. Paez Jimenez A; Sharaf Eldin N; Rimlinger F; El-Daly M; El-Hariri H; El-Hoseiny M; Mohsen A; Mostafa A; Delarocque-Astagneau E; Abdel-Hamid M; Fontanet A; Mohamed MK; Thiers V Gut; 2010 Nov; 59(11):1554-60. PubMed ID: 20947889 [TBL] [Abstract][Full Text] [Related]
8. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Frank C; Mohamed MK; Strickland GT; Lavanchy D; Arthur RR; Magder LS; El Khoby T; Abdel-Wahab Y; Aly Ohn ES; Anwar W; Sallam I Lancet; 2000 Mar; 355(9207):887-91. PubMed ID: 10752705 [TBL] [Abstract][Full Text] [Related]
9. Hepatitis C transmission and treatment as prevention - The role of the injecting network. Hellard M; McBryde E; Sacks Davis R; Rolls DA; Higgs P; Aitken C; Thompson A; Doyle J; Pattison P; Robins G Int J Drug Policy; 2015 Oct; 26(10):958-62. PubMed ID: 26072105 [TBL] [Abstract][Full Text] [Related]
10. Is the hepatitis C virus epidemic over in Egypt? Incidence and risk factors of new hepatitis C virus infections. Mostafa A; Taylor SM; el-Daly M; el-Hoseiny M; Bakr I; Arafa N; Thiers V; Rimlinger F; Abdel-Hamid M; Fontanet A; Mohamed MK Liver Int; 2010 Apr; 30(4):560-6. PubMed ID: 20141592 [TBL] [Abstract][Full Text] [Related]
11. Health care-associated hepatitis C virus infection. Pozzetto B; Memmi M; Garraud O; Roblin X; Berthelot P World J Gastroenterol; 2014 Dec; 20(46):17265-78. PubMed ID: 25516637 [TBL] [Abstract][Full Text] [Related]
12. Curbing hepatitis C virus spread in Egypt. Negro F Lancet Glob Health; 2014 Sep; 2(9):e495-e496. PubMed ID: 25304405 [No Abstract] [Full Text] [Related]
13. HCV transmission in industrialized countries and resource-constrained areas. Thursz M; Fontanet A Nat Rev Gastroenterol Hepatol; 2014 Jan; 11(1):28-35. PubMed ID: 24080775 [TBL] [Abstract][Full Text] [Related]
14. Hepatitis C in a community in Upper Egypt: I. Cross-sectional survey. Nafeh MA; Medhat A; Shehata M; Mikhail NN; Swifee Y; Abdel-Hamid M; Watts S; Fix AD; Strickland GT; Anwar W; Sallam I Am J Trop Med Hyg; 2000; 63(5-6):236-41. PubMed ID: 11421370 [TBL] [Abstract][Full Text] [Related]
15. Dynamic modelling of hepatitis C virus transmission among people who inject drugs: a methodological review. Cousien A; Tran VC; Deuffic-Burban S; Jauffret-Roustide M; Dhersin JS; Yazdanpanah Y J Viral Hepat; 2015 Mar; 22(3):213-29. PubMed ID: 25270261 [TBL] [Abstract][Full Text] [Related]
17. Impact of treatment on hepatitis C virus transmission and incidence in Egypt: A case for treatment as prevention. Ayoub HH; Abu-Raddad LJ J Viral Hepat; 2017 Jun; 24(6):486-495. PubMed ID: 28039923 [TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus acquisition among Egyptians: analysis of a 10-year surveillance of acute hepatitis C. Mohsen A; Bernier A; LeFouler L; Delarocque-Astagneau E; El-Daly M; El-Kafrawy S; El-Mango S; Abdel-Hamid M; Gadallah M; Esmat G; Mohamed MK; Fontanet A Trop Med Int Health; 2015 Jan; 20(1):89-97. PubMed ID: 25336067 [TBL] [Abstract][Full Text] [Related]
19. Vertically acquired hepatitis C virus infection: Correlates of transmission and disease progression. Tovo PA; Calitri C; Scolfaro C; Gabiano C; Garazzino S World J Gastroenterol; 2016 Jan; 22(4):1382-92. PubMed ID: 26819507 [TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus infection among healthy Egyptian children: prevalence and risk factors. Barakat SH; El-Bashir N J Viral Hepat; 2011 Nov; 18(11):779-84. PubMed ID: 21992795 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]